Włodarczak, A.; Łanocha, M.; Szudrowicz, M.; Barycki, M.; Gosiewska, A.; Kulczycki, J.J.; Lesiak, M.; Doroszko, A.; Rola, P.
The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome. J. Clin. Med. 2021, 10, 3166.
https://doi.org/10.3390/jcm10143166
AMA Style
Włodarczak A, Łanocha M, Szudrowicz M, Barycki M, Gosiewska A, Kulczycki JJ, Lesiak M, Doroszko A, Rola P.
The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 2021; 10(14):3166.
https://doi.org/10.3390/jcm10143166
Chicago/Turabian Style
Włodarczak, Adrian, Magdalena Łanocha, Marek Szudrowicz, Mateusz Barycki, Alicja Gosiewska, Jan Jakub Kulczycki, Maciej Lesiak, Adrian Doroszko, and Piotr Rola.
2021. "The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome" Journal of Clinical Medicine 10, no. 14: 3166.
https://doi.org/10.3390/jcm10143166
APA Style
Włodarczak, A., Łanocha, M., Szudrowicz, M., Barycki, M., Gosiewska, A., Kulczycki, J. J., Lesiak, M., Doroszko, A., & Rola, P.
(2021). The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome. Journal of Clinical Medicine, 10(14), 3166.
https://doi.org/10.3390/jcm10143166
